Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Zelickson, Susan Walgrave, Munir Al‐Arashi, G. Altshuler, I. Yaroslavsky, J. Childs, Richard Cohen, A. Erofeev, Erminaldo Depina, M. Smirnov, D. Kist, D. Tabatadze (2009)
Semi‐Automated method of analysis of horizontal histological sections of skin for objective evaluation of fractional devicesLasers in Surgery and Medicine, 41
D. Manstein, G. Herron, R. Sink, H. Tanner, R. Anderson (2004)
Fractional Photothermolysis: A New Concept for Cutaneous Remodeling Using Microscopic Patterns of Thermal InjuryLasers in Surgery and Medicine, 34
B. Hantash, Vikramaditya Bedi, Kin Chan, C. Zachary (2007)
Ex vivo histological characterization of a novel ablative fractional resurfacing deviceLasers in Surgery and Medicine, 39
B. Hantash, Vikramaditya Bedi, B. Kapadia, Z. Rahman, Kerrie Jiang, H. Tanner, Kin Chan, C. Zachary (2007)
In vivo histological evaluation of a novel ablative fractional resurfacing deviceLasers in Surgery and Medicine, 39
J. Ostertag, P. Quaedvlieg, M. Neumann, G. Krekels (2006)
Recurrence Rates and Long‐Term Follow‐Up After Laser Resurfacing as a Treatment for Widespread Actinic Keratoses in the Face and on the ScalpDermatologic Surgery, 32
L. Naldi, T. Diepgen (2002)
The epidemiology of skin cancerBritish Journal of Dermatology, 146
M. Hædersdal, F. Sakamoto, W. Farinelli, A. Doukas, J. Tam, R. Anderson (2010)
Fractional CO2 laser‐assisted drug deliveryLasers in Surgery and Medicine, 42
Christina Haak, M. Illes, U. Paasch, M. Hædersdal (2011)
Histological evaluation of vertical laser channels from ablative fractional resurfacing: an ex vivo pig skin modelLasers in Medical Science, 26
I. Allemann, Joely Kaufman (2009)
Fractional photothermolysis—an updateLasers in Medical Science, 25
U. Paasch, M. Haedersdal (2011)
Laser systems for ablative fractional resurfacingExpert Review of Medical Devices, 8
R. Geronemus (2006)
Fractional photothermolysis: Current and future applicationsLasers in Surgery and Medicine, 38
S. Grunewald, M. Bodendorf, J. Simon, U. Paasch (2011)
Update dermatologic laser therapyJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 9
L. Goldberg, A. Mamelak (2010)
Review ofactinic keratosis. Part I: etiology, epidemiology and clinical presentation.Journal of drugs in dermatology : JDD, 9 9
(2007)
Guidelines on the use of photodynamic therapy for non - melanoma skin cancer . An international consensus
A. Memon, J. Tomenson, J. Bothwell, P. Friedmann (2000)
Prevalence of solar damage and actinic keratosis in a Merseyside populationBritish Journal of Dermatology, 142
V. Madan, J. Lear, R. Szeimies (2010)
Non-melanoma skin cancerThe Lancet, 375
(1994)
Cutaneously laser surgery
M. Bodendorf, S. Grunewald, T. Wetzig, J. Simon, U. Paasch (2009)
Fractional laser skin therapyJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 7
M. Haedersdal, M. Haedersdal, J. Katsnelson, F. Sakamoto, F. Sakamoto, W. Farinelli, A. Doukas, J. Tam, R. Anderson (2011)
Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatmentLasers in Surgery and Medicine, 43
(2008)
Bioavailability in basal cell carcinomas : a perfusion study using microdialysis in vivo
L. Braathen, R. Szeimies, N. Basset-Seguin, R. Bissonnette, P. Foley, D. Pariser, R. Roelandts, A. Wennberg, C. Morton (2007)
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.Journal of the American Academy of Dermatology, 56 1
C. Sandberg, C. Halldin, M. Ericson, M. Ericson, O. Larkö, A. Krogstad, A. Wennberg (2008)
Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivoBritish Journal of Dermatology, 159
Lasers Med Sci (2012) 27:675–679 DOI 10.1007/s10103-011-0997-8 BRIEF REPORT Lesion dimensions following ablative fractional laser treatment in non-melanoma skin cancer and premalignant lesions Katrine Togsverd-Bo & Uwe Paasch & Christina S. Haak & Merete Haedersdal Received: 18 August 2011 /Accepted: 12 September 2011 /Published online: 1 October 2011 Springer-Verlag London Ltd 2011 Introduction (Er:YAG, 2,940 nm) and yttrium scandium gallium garnet lasers (YSGG, 2,790 nm), all of which have a high Non-melanoma skin cancer (NMSC), which comprises absorption in the target chromophore, water, and thus basal cell carcinomas (BCC) and squamous cell carcinomas target intra- and extracellular water-rich components such (SCC), is the most common human cancer with an as keratinocytes and vessels [6]. AFXL resurfacing is estimated incidence of more than one million new cancers currently used in the treatment of photodamaged skin, per year alone in the USA [1–5]. SCC may be preceded by wrinkles, and acne and burn scars, but so far not for precursor lesions such as actinic keratoses (AK) and SCC in malignant or premalignant lesions, which is the case for situ (Bowen’s disease), whereas BCCs are regarded as conventional ablative lasers [9–13]. invasive tumours from the beginning. The incidence of the Theimmediatetissuedamageafter AFXL
Lasers in Medical Science – Springer Journals
Published: Oct 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.